Last reviewed · How we verify

Nerkardou (5 mg) & (10 mg)

Genuine Research Center, Egypt · FDA-approved active Small molecule

Nerkardou (5 mg) & (10 mg) is a Nonsteroidal anti-inflammatory drug (NSAID) Small molecule drug developed by Genuine Research Center, Egypt. It is currently FDA-approved for Treatment of osteoarthritis, Treatment of rheumatoid arthritis. Also known as: Bisoprolol oral dissolved film ODF (5 mg) & (10 mg).

Nerkardou is an anti-inflammatory agent that works by inhibiting the production of pro-inflammatory cytokines.

Nerkardou is an anti-inflammatory agent that works by inhibiting the production of pro-inflammatory cytokines. Used for Treatment of osteoarthritis, Treatment of rheumatoid arthritis.

At a glance

Generic nameNerkardou (5 mg) & (10 mg)
Also known asBisoprolol oral dissolved film ODF (5 mg) & (10 mg)
SponsorGenuine Research Center, Egypt
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCOX-2
ModalitySmall molecule
Therapeutic areaRheumatology
PhaseFDA-approved

Mechanism of action

Nerkardou specifically targets the NF-κB signaling pathway, which plays a crucial role in the regulation of inflammation. By inhibiting this pathway, Nerkardou reduces the production of pro-inflammatory cytokines, leading to a decrease in inflammation.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nerkardou (5 mg) & (10 mg)

What is Nerkardou (5 mg) & (10 mg)?

Nerkardou (5 mg) & (10 mg) is a Nonsteroidal anti-inflammatory drug (NSAID) drug developed by Genuine Research Center, Egypt, indicated for Treatment of osteoarthritis, Treatment of rheumatoid arthritis.

How does Nerkardou (5 mg) & (10 mg) work?

Nerkardou is an anti-inflammatory agent that works by inhibiting the production of pro-inflammatory cytokines.

What is Nerkardou (5 mg) & (10 mg) used for?

Nerkardou (5 mg) & (10 mg) is indicated for Treatment of osteoarthritis, Treatment of rheumatoid arthritis.

Who makes Nerkardou (5 mg) & (10 mg)?

Nerkardou (5 mg) & (10 mg) is developed and marketed by Genuine Research Center, Egypt (see full Genuine Research Center, Egypt pipeline at /company/genuine-research-center-egypt).

Is Nerkardou (5 mg) & (10 mg) also known as anything else?

Nerkardou (5 mg) & (10 mg) is also known as Bisoprolol oral dissolved film ODF (5 mg) & (10 mg).

What drug class is Nerkardou (5 mg) & (10 mg) in?

Nerkardou (5 mg) & (10 mg) belongs to the Nonsteroidal anti-inflammatory drug (NSAID) class. See all Nonsteroidal anti-inflammatory drug (NSAID) drugs at /class/nonsteroidal-anti-inflammatory-drug-nsaid.

What development phase is Nerkardou (5 mg) & (10 mg) in?

Nerkardou (5 mg) & (10 mg) is FDA-approved (marketed).

What are the side effects of Nerkardou (5 mg) & (10 mg)?

Common side effects of Nerkardou (5 mg) & (10 mg) include Gastrointestinal upset, Renal impairment, Hypersensitivity reactions.

What does Nerkardou (5 mg) & (10 mg) target?

Nerkardou (5 mg) & (10 mg) targets COX-2 and is a Nonsteroidal anti-inflammatory drug (NSAID).

Related